227 related articles for article (PubMed ID: 32427076)
1. Clinically reliable cognitive decline in relapsing remitting multiple sclerosis: Is it the tip of the iceberg?
Andravizou A; Siokas V; Artemiadis A; Bakirtzis C; Aloizou AM; Grigoriadis N; Kosmidis MH; Nasios G; Messinis L; Hadjigeorgiou G; Dardiotis E; Peristeri E
Neurol Res; 2020 Jul; 42(7):575-586. PubMed ID: 32427076
[TBL] [Abstract][Full Text] [Related]
2. Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.
Eijlers AJC; van Geest Q; Dekker I; Steenwijk MD; Meijer KA; Hulst HE; Barkhof F; Uitdehaag BMJ; Schoonheim MM; Geurts JJG
Brain; 2018 Sep; 141(9):2605-2618. PubMed ID: 30169585
[TBL] [Abstract][Full Text] [Related]
3. Clinical and MRI predictors of cognitive decline in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study.
Dong X; Xu G; Wang J; Yin N; Meng N
Mult Scler Relat Disord; 2022 Sep; 65():103838. PubMed ID: 35749960
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
[TBL] [Abstract][Full Text] [Related]
5. Association between symbol digit modalities test and regional cortex thickness in young adults with relapsing-remitting multiple sclerosis.
Tao Y; XueSong Z; Xiao Y; YueZhi K; Xin W; YanPing T; Lei W; YongPing F
Clin Neurol Neurosurg; 2021 Aug; 207():106805. PubMed ID: 34280674
[TBL] [Abstract][Full Text] [Related]
6. Voxel-based analysis of gray matter relaxation rates shows different correlation patterns for cognitive impairment and physical disability in relapsing-remitting multiple sclerosis.
Cassiano MT; Lanzillo R; Alfano B; Costabile T; Comerci M; Prinster A; Moccia M; Megna R; Morra VB; Quarantelli M; Brunetti A
Neuroimage Clin; 2020; 26():102201. PubMed ID: 32062567
[TBL] [Abstract][Full Text] [Related]
7. Predicting clinical progression and cognitive decline in patients with relapsing-remitting multiple sclerosis: a 6-year follow-up study.
Kania K; Pawlak MA; Forycka M; Wiłkość-Dębczyńska M; Michalak S; Łukaszewska A; Wyciszkiewicz A; Wypych A; Serafin Z; Marcinkowska J; Kozubski W; Kalinowska-Łyszczarz A
Neurol Neurochir Pol; 2024; 58(2):176-184. PubMed ID: 38324117
[TBL] [Abstract][Full Text] [Related]
8. Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.
Gioia MC; Cerasa A; Liguori M; Passamonti L; Condino F; Vercillo L; Valentino P; Clodomiro A; Quattrone A; Fera F
Brain Res; 2007 Sep; 1167():71-9. PubMed ID: 17689504
[TBL] [Abstract][Full Text] [Related]
9. Cerebellar contribution to motor and cognitive performance in multiple sclerosis: An MRI sub-regional volumetric analysis.
D'Ambrosio A; Pagani E; Riccitelli GC; Colombo B; Rodegher M; Falini A; Comi G; Filippi M; Rocca MA
Mult Scler; 2017 Aug; 23(9):1194-1203. PubMed ID: 27760859
[TBL] [Abstract][Full Text] [Related]
10. Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status.
Papathanasiou A; Messinis L; Zampakis P; Panagiotakis G; Gourzis P; Georgiou V; Papathanasopoulos P
J Neurol Sci; 2015 Nov; 358(1-2):236-42. PubMed ID: 26359854
[TBL] [Abstract][Full Text] [Related]
11. Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
Hofstetter L; Naegelin Y; Filli L; Kuster P; Traud S; Smieskova R; Mueller-Lenke N; Kappos L; Gass A; Sprenger T; Penner IK; Nichols TE; Vrenken H; Barkhof F; Polman C; Radue EW; Borgwardt SJ; Bendfeldt K
Mult Scler; 2014 Feb; 20(2):202-13. PubMed ID: 23804554
[TBL] [Abstract][Full Text] [Related]
12. Thalamus volume change and cognitive impairment in early relapsing-remitting multiple sclerosis patients.
Rojas JI; Murphy G; Sanchez F; Patrucco L; Fernandez MC; Miguez J; Funes J; Golimstok A; Cristiano E
Neuroradiol J; 2018 Aug; 31(4):350-355. PubMed ID: 29869576
[TBL] [Abstract][Full Text] [Related]
13. The association between olfactory bulb volume, cognitive dysfunction, physical disability and depression in multiple sclerosis.
Yaldizli Ö; Penner IK; Yonekawa T; Naegelin Y; Kuhle J; Pardini M; Chard DT; Stippich C; Kira JI; Bendfeldt K; Amann M; Radue EW; Kappos L; Sprenger T
Eur J Neurol; 2016 Mar; 23(3):510-9. PubMed ID: 26699999
[TBL] [Abstract][Full Text] [Related]
14. Cortical quantitative MRI parameters are related to the cognitive status in patients with relapsing-remitting multiple sclerosis.
van Wijnen A; Petrov F; Maiworm M; Frisch S; Foerch C; Hattingen E; Steinmetz H; Klein JC; Deichmann R; Wagner M; Gracien RM
Eur Radiol; 2020 Feb; 30(2):1045-1053. PubMed ID: 31602513
[TBL] [Abstract][Full Text] [Related]
15. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
Zhao X; Yang T; Cheng F; Yang S; Zhu W; Li S; Fan Y
J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413
[TBL] [Abstract][Full Text] [Related]
16. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
[TBL] [Abstract][Full Text] [Related]
17. Regional brain atrophy is related to social cognition impairment in multiple sclerosis.
Labbe TP; Montalba C; Zurita M; Ciampi EL; Cruz JP; Vasquez M; Uribe S; Crossley N; Cárcamo C
Arq Neuropsiquiatr; 2021 Aug; 79(8):666-675. PubMed ID: 34550187
[TBL] [Abstract][Full Text] [Related]
18. Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis.
Nygaard GO; Walhovd KB; Sowa P; Chepkoech JL; Bjørnerud A; Due-Tønnessen P; Landrø NI; Damangir S; Spulber G; Storsve AB; Beyer MK; Fjell AM; Celius EG; Harbo HF
Mult Scler; 2015 Apr; 21(4):402-14. PubMed ID: 25139946
[TBL] [Abstract][Full Text] [Related]
19. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
Sacco R; Bisecco A; Corbo D; Della Corte M; d'Ambrosio A; Docimo R; Gallo A; Esposito F; Esposito S; Cirillo M; Lavorgna L; Tedeschi G; Bonavita S
J Neurol; 2015 Jul; 262(7):1691-7. PubMed ID: 25957638
[TBL] [Abstract][Full Text] [Related]
20. Deep grey matter MRI abnormalities and cognitive function in relapsing-remitting multiple sclerosis.
Debernard L; Melzer TR; Alla S; Eagle J; Van Stockum S; Graham C; Osborne JR; Dalrymple-Alford JC; Miller DH; Mason DF
Psychiatry Res; 2015 Dec; 234(3):352-61. PubMed ID: 26602610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
